These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 18695170)
41. Correct use of proton pump inhibitors for gastro-oesophageal reflux disease. Hatlebakk JG; Emken BE; Glazkov V; Hoff DA; Hausken T Tidsskr Nor Laegeforen; 2013 Jan; 133(1):43-6. PubMed ID: 23306993 [No Abstract] [Full Text] [Related]
42. Long-term use of PPIs in children: we have questions. Hassall E; Owen D Dig Dis Sci; 2008 Apr; 53(4):1158-60, author reply 1161-2. PubMed ID: 18259863 [No Abstract] [Full Text] [Related]
43. Letter by Montenegro and Lundberg regarding article, "unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine". Montenegro MF; Lundberg JO Circulation; 2014 Apr; 129(13):e426. PubMed ID: 24687652 [No Abstract] [Full Text] [Related]
44. [Long-term use of proton pump inhibitors--really harmless?]. Haag S Dtsch Med Wochenschr; 2013 Nov; 138(45):2319-21. PubMed ID: 24163169 [No Abstract] [Full Text] [Related]
45. Biological plausibility between proton pump inhibitory therapy and hip fracture: hyperhomocysteinemia can be the link. Roblin X; Phelip JM Am J Gastroenterol; 2009 Apr; 104(4):1052. PubMed ID: 19240711 [No Abstract] [Full Text] [Related]
46. Response to letters regarding article, "unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine". Ghebremariam YT; Lee JC; LePendu P; Erlanson DA; Slaviero A; Shah NH; Leiper JM; Cooke JP Circulation; 2014 Apr; 129(13):e428. PubMed ID: 24687654 [No Abstract] [Full Text] [Related]
48. Letter by Pinheiro et al regarding article, "unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine". Pinheiro LC; Amaral JH; Tanus-Santos JE Circulation; 2014 Apr; 129(13):e427. PubMed ID: 24687653 [No Abstract] [Full Text] [Related]
49. Letter by Chyrchel et al regarding article, "unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine". Chyrchel B; Chyrchel M; Surdacki A Circulation; 2014 Apr; 129(13):e425. PubMed ID: 24687651 [No Abstract] [Full Text] [Related]
51. Infants and proton pump inhibitors: tribulations, no trials. Orenstein SR; Hassall E J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):395-8. PubMed ID: 18030202 [No Abstract] [Full Text] [Related]
52. The relationship among proton pump inhibitors, bone disease and fracture. Targownik LE; Leslie WD Expert Opin Drug Saf; 2011 Nov; 10(6):901-12. PubMed ID: 21599546 [TBL] [Abstract][Full Text] [Related]
53. Proton Pump Inhibitor Use and Outcomes in Children With Respiratory Symptoms. Rosen R; Rahbar R JAMA Otolaryngol Head Neck Surg; 2018 Jul; 144(7):555-556. PubMed ID: 29800938 [No Abstract] [Full Text] [Related]
54. [Gastroesophageal reflux and proton pump inhibitors: panacea or prescription abuse?]. Mouterde O; Bellaïche M; Dumant C; Mallet E Arch Pediatr; 2010 Jun; 17(6):739-40. PubMed ID: 20654868 [No Abstract] [Full Text] [Related]
55. Proton pump inhibitor use and enteric infections. Dial MS Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S10-6. PubMed ID: 19262540 [TBL] [Abstract][Full Text] [Related]
56. Proton Pump Inhibitors: The Good, Bad, and Ugly. Schnoll-Sussman F; Niec R; Katz PO Gastrointest Endosc Clin N Am; 2020 Apr; 30(2):239-251. PubMed ID: 32146944 [TBL] [Abstract][Full Text] [Related]
57. The effects of three alternative treatment strategies after 8 weeks of proton pump inhibitor therapy for GERD in children. Lee JH; Kim MJ; Lee JS; Choe YH Arch Dis Child; 2011 Jan; 96(1):9-13. PubMed ID: 20870626 [TBL] [Abstract][Full Text] [Related]
58. Treatment of GERD and proton pump inhibitor use in the elderly: practical approaches and frequently asked questions. Scholl S; Dellon ES; Shaheen NJ Am J Gastroenterol; 2011 Mar; 106(3):386-92. PubMed ID: 21378759 [No Abstract] [Full Text] [Related]
60. Efficacy and safety of proton pump inhibitors in the management of pediatric gastroesophageal reflux disease. Tjon JA; Pe M; Soscia J; Mahant S Pharmacotherapy; 2013 Sep; 33(9):956-71. PubMed ID: 23712734 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]